Menu Search
Equities

Concord Medical Services Holdings Ltd

C2C:FRA

Concord Medical Services Holdings Ltd

Actions
  • Price (EUR)6.25
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-47.03%
  • Beta--
Data delayed at least 15 minutes, as of Jul 29 2024 07:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.

  • Revenue in USD (TTM)76.22m
  • Net income in USD-42.22m
  • Incorporated2007
  • Employees727.00
  • Location
    Concord Medical Services Holdings LtdRoom 26A1-26A5, East Tower, Hanwei, BuilBEIJING 100020ChinaCHN
  • Phone+86 1 058256867
  • Websitehttps://www.concordmedical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.